Comparison of Capnography and Blood Gas PaCO₂ Measurements (CAPNO-PaCO2)

Correlation of End-Tidal Carbon Dioxide Values Measured by Different Capnographic Devices With Blood Gas Analysis in Patients Presenting to Emergency Department: A Prospective Non-Randomized Study

Capnography provides continuous, non-invasive assessment of ventilation by measuring end-tidal carbon dioxide (EtCO₂). Different capnographic technologies, including mainstream, sidestream, and microstream capnography, may produce different EtCO₂ measurements depending on their sampling and measurement techniques.

This prospective, non-randomized observational study was designed to compare EtCO₂ values obtained using mainstream, sidestream, and microstream capnography with carbon dioxide partial pressure (PCO₂) values obtained from clinically indicated blood gas analysis in adult patients presenting to the emergency department.

For each participant, EtCO₂ measurements were obtained using the three capnographic methods in close temporal proximity to blood gas sampling. The relationship and agreement between blood gas PCO₂ and EtCO₂ measurements were planned to be evaluated using correlation analyses and Bland-Altman analysis. Additional analyses were planned according to whether the blood gas sample was arterial or venous.

Study Overview

Detailed Description

This prospective, non-randomized, cross-sectional observational study was conducted in the Emergency Department of the University of Health Sciences Sultan II. Abdülhamid Han Training and Research Hospital.

The study population consisted of adult patients presenting to the emergency department for whom blood gas analysis was requested by the treating physician as part of routine clinical care.

The primary objective of the study was to evaluate the agreement between blood gas PCO₂ measurements and end-tidal carbon dioxide (EtCO₂) values obtained using three different capnographic technologies: mainstream, sidestream, and microstream capnography.

A secondary objective was to compare the agreement of each capnographic method with blood gas PCO₂ measurements and to evaluate whether the relationship differed according to the type of blood gas sample, arterial or venous.

Eligible participants were adults aged 18 years or older whose level of consciousness and clinical condition were suitable for EtCO₂ measurement and who provided informed consent. Exclusion criteria included age younger than 18 years, pregnancy, refusal or inability to provide informed consent, Glasgow Coma Scale score below 15, and clinical or anatomical conditions preventing appropriate capnographic measurement. Patients with sepsis, diabetic ketoacidosis, hypovolemic shock, acute major bleeding, or severe dehydration were also excluded because these conditions could potentially affect the relationship between EtCO₂ and blood gas PCO₂.

For each participant, EtCO₂ measurements were obtained using mainstream, sidestream, and microstream capnography. Blood gas sampling was performed simultaneously with or in close temporal proximity to the capnographic measurements.

For mainstream capnography, participants breathed through an airway interface connected directly to the capnography sensor, and EtCO₂ measurements were recorded after a stable capnogram had been obtained over consecutive respiratory cycles. Sidestream and microstream EtCO₂ measurements were obtained using the corresponding sampling interfaces connected to the respective capnography monitors.

Demographic and clinical variables, including age, sex, height, weight, smoking status, relevant chronic diseases, and blood gas parameters, were recorded.

The association between blood gas PCO₂ and EtCO₂ values obtained using each capnographic method was planned to be evaluated using correlation analysis. Agreement between blood gas PCO₂ and EtCO₂ measurements was planned to be assessed using Bland-Altman analysis. Prespecified subgroup analyses were planned according to whether the blood gas sample was arterial or venous.

Study Type

Observational

Enrollment (Actual)

135

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Istanbul
      • Istanbul, Istanbul, Turkey (Türkiye), 34668
        • University of Health Sciences, Sultan II. Abdülhamid Han Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The study population consisted of adult patients presenting to the Emergency Department of the University of Health Sciences Sultan II. Abdülhamid Han Training and Research Hospital between May 1, 2024, and July 1, 2024, for whom blood gas analysis was requested by the treating physician as part of routine clinical care. Eligible patients were required to be clinically suitable for end-tidal carbon dioxide (EtCO₂) measurement and to provide informed consent. A total of 135 participants who met the eligibility criteria were included in the study.

Description

Inclusion Criteria:Age 18 years or older. Presentation to the emergency department with a clinical indication for blood gas analysis as determined by the treating physician.

Level of consciousness and clinical condition suitable for end-tidal carbon dioxide (EtCO₂) measurement.

Ability and willingness to provide informed consent for participation in the study.

Exclusion Criteria:Age younger than 18 years. Refusal or inability to provide informed consent. Pregnancy. Glasgow Coma Scale score below 15. Any anatomical deformity or condition preventing appropriate capnography measurement.

Sepsis. Diabetic ketoacidosis. Hypovolemic shock. Acute major bleeding. Severe dehydration.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: OTHER
  • Time Perspectives: PROSPECTIVE

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Arterial Blood Gas Cohort

Adult patients presenting to the emergency department who underwent clinically indicated arterial blood gas analysis. In each participant, end-tidal carbon dioxide (etCO₂) was measured using mainstream, sidestream, and microstream capnography simultaneously or in close temporal proximity to blood gas sampling. Capnographic etCO₂ measurements were compared with arterial PaCO₂ values. No randomization was performed, and all three capnographic methods were applied to each participant.

End-tidal carbon dioxide (etCO2) was measured using mainstream capnography. Participants were asked to breathe through an endotracheal tube connected to the capnography sensor, and monitoring was continued for at least six breaths to obtain a stable measurement. The mainstream etCO2 value was recorded simultaneously or in close temporal proximity to clinically indicated blood gas sampling and was compared with the PCO2 value obtained from the blood gas analysis.

End-tidal carbon dioxide (etCO2) was measured using sidestream capnography. A nasal cannula connected to the capnography monitor was placed in the participant's nostrils, and exhaled carbon dioxide was sampled during spontaneous breathing. The sidestream etCO2 value was recorded simultaneously or in close temporal proximity to clinically indicated blood gas sampling and was compared with the PCO2 value obtained from the blood gas analysis.

End-tidal carbon dioxide (etCO2) was measured using microstream capnography. A nasal cannula connected to the capnography monitor was placed in the participant's nostrils, and exhaled carbon dioxide was sampled during spontaneous breathing. The microstream etCO2 value was recorded simultaneously or in close temporal proximity to clinically indicated blood gas sampling and was compared with the PCO2 value obtained from the blood gas analysis.

Venous Blood Gas Cohort

Adult patients presenting to the emergency department who underwent clinically indicated venous blood gas analysis. In each participant, end-tidal carbon dioxide (etCO₂) was measured using mainstream, sidestream, and microstream capnography simultaneously or in close temporal proximity to blood gas sampling. Capnographic etCO₂ measurements were compared with venous blood gas PCO₂ values. No randomization was performed, and all three capnographic methods were applied to each participant.

End-tidal carbon dioxide (etCO2) was measured using mainstream capnography. Participants were asked to breathe through an endotracheal tube connected to the capnography sensor, and monitoring was continued for at least six breaths to obtain a stable measurement. The mainstream etCO2 value was recorded simultaneously or in close temporal proximity to clinically indicated blood gas sampling and was compared with the PCO2 value obtained from the blood gas analysis.

End-tidal carbon dioxide (etCO2) was measured using sidestream capnography. A nasal cannula connected to the capnography monitor was placed in the participant's nostrils, and exhaled carbon dioxide was sampled during spontaneous breathing. The sidestream etCO2 value was recorded simultaneously or in close temporal proximity to clinically indicated blood gas sampling and was compared with the PCO2 value obtained from the blood gas analysis.

End-tidal carbon dioxide (etCO2) was measured using microstream capnography. A nasal cannula connected to the capnography monitor was placed in the participant's nostrils, and exhaled carbon dioxide was sampled during spontaneous breathing. The microstream etCO2 value was recorded simultaneously or in close temporal proximity to clinically indicated blood gas sampling and was compared with the PCO2 value obtained from the blood gas analysis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Agreement Between PaCO₂ and EtCO₂ Measurements Obtained Using Mainstream, Sidestream, and Microstream Capnography
Time Frame: Within 1 day of emergency department assessment

Agreement between blood gas PaCO₂ and end-tidal carbon dioxide (EtCO₂) measurements obtained using mainstream, sidestream, and microstream capnography. Agreement was assessed using Bland-Altman analysis by calculating the mean difference (bias) and 95% limits of agreement for each capnography method compared with blood gas PaCO₂.

Within 1 day of emergency department assessment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Erdem Çevik, Prof., M.D., University of Health Sciences, Sultan II. Abdülhamid Han Training and Research Hospital
  • Study Director: Melih Arınç, M.D., University of Health Sciences, Sultan II. Abdülhamid Han Training and Research Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2024

Primary Completion (Actual)

July 1, 2024

Study Completion (Actual)

July 1, 2024

Study Registration Dates

First Submitted

September 3, 2026

First Submitted That Met QC Criteria

September 16, 2026

First Posted (Actual)

September 22, 2026

Study Record Updates

Last Update Posted (Actual)

September 22, 2026

Last Update Submitted That Met QC Criteria

September 16, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There is no formal plan for public sharing of individual participant data. De-identified data may be made available by the corresponding author upon reasonable request, subject to applicable ethical and institutional requirements.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe